转移性乳腺癌
人表皮生长因子受体2
乳腺癌
肿瘤科
HER2阴性
内科学
医学
癌症
作者
Bertha Eisses,Jasper J. L. van Geel,Adrienne H. Brouwers,Frederike Bensch,Sjoerd G. Elias,Evelien Kuip,Agnes Jager,Bert van der Vegt,Marjolijn N. Lub–de Hooge,Jasper Emmering,Anne I.J. Arens,Gerben J. C. Zwezerijnen,Daniëlle J. Vugts,C. Willemien Menke‐van der Houven van Oordt,Elisabeth G.E. de Vries,Carolina P. Schröder
标识
DOI:10.2967/jnumed.124.267636
摘要
Understanding which patients with human epidermal growth factor receptor 2 (HER2)-negative or -low metastatic breast cancer (MBC) benefit from HER2-targeted strategies is urgently needed. We assessed the whole-body heterogeneity of HER2 expression on
科研通智能强力驱动
Strongly Powered by AbleSci AI